Talita Duartes-Salles

Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)

Presentation(s):

• OP-26C - Sensitivity Analysis of Design Choices for Estimating Incidence Rates of Adverse Events of Special Interest in Vaccine Safety

  Monday, August 23, 2021
  1:45 PM – 3:30 PM US Eastern Time

• OP-23A - Heterogeneity and Temporal Variation in the Management of COVID-19: A Multinational Drug Utilisation Study Including 274,719 Hospitalised Patients From, the United States of America, China, Spain, and South Korea

  Tuesday, August 24, 2021
  1:45 PM – 3:30 PM US Eastern Time

• SP07C - Performance of Different Definitions for COVID-19 Infection Across European Databases

  Tuesday, August 24, 2021
  3:30 PM – 4:45 PM US Eastern Time

• OP-5A - Descriptive Epidemiology of Adverse Events of Special Interest for COVID-19 Vaccines Across 7 Countries and 4 Continents: A Multinational Network Cohort Study

  Wednesday, August 25, 2021
  11:45 AM – 1:30 PM US Eastern Time

• OP-12B - Ranitidine and Other histamine2-receptor Antagonists – a Rapid Response Drug Utilisation Study Using Electronic Health Care Data from Six European Countries

  Wednesday, August 25, 2021
  11:45 AM – 1:30 PM US Eastern Time